Akero Therapeutics Inc buy Morgan Stanley
Start price
11.10.23
/
50%
€14.00
Target price
11.10.24
€31.05
Performance (%)
71.57%
Price
20.08.24
€24.02
Summary
This prediction is currently active. With a performance of 71.57% the BUY prediction by Morgan_Stanley is a big success. This prediction currently runs until 11.10.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akero Therapeutics Inc | - | - |
iShares Core DAX® | -0.372% | 5.236% |
iShares Nasdaq 100 | -1.950% | 1.680% |
iShares Nikkei 225® | -1.690% | 7.286% |
iShares S&P 500 | -0.399% | 2.379% |
Comments by Morgan_Stanley for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target lowered by analysts at Morgan Stanley from $70.00 to $33.00. They now have an "overweight" rating on the stock.
Ratings data for AKRO provided by MarketBeat